Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo
NCT ID: NCT04349956
Last Updated: 2020-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
161 participants
OBSERVATIONAL
2020-04-20
2020-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients from a randomized placebo-controlled study of UBX0101
Patients with moderate to severe, painful OA of the knee who participated in a randomized, placebo-controlled study of UBX0101.
UBX0101 or placebo
This is an observational study. No intervention is administered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UBX0101 or placebo
This is an observational study. No intervention is administered.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are willing and able to consent to having blinded, long-term follow-up; consent via legally authorized representative is not accepted.
Exclusion Criteria
* Patients who are scheduled to undergo knee arthroplasty on either knee during the study.
* Patients who anticipate arthroscopic surgery on either knee at any time during the study.
* Patients who plan to receive treatment with an anti-nerve growth factor agent during the study.
* Patients who plan to participate in another investigational study (including interventional studies of investigational drugs and investigational treatments \[e.g., braces, stem cells, and procedures\]) during the study.
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Biotechnology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
UNITY Biotechnology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coastal Clinical Research, LLC.
Mobile, Alabama, United States
Fiel Family and Sports Medicine
Tempe, Arizona, United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Biosolutions Clinical Research Center
La Mesa, California, United States
Diablo Clinical Research
Walnut Creek, California, United States
Well-Pharma Medical Research
Miami, Florida, United States
Precision Clinical Research
Sunrise, Florida, United States
Premier Medical Associates
The Villages, Florida, United States
Chicago Clinical Research Institute
Chicago, Illinois, United States
The Alliance for Multispecialty Research
Wichita, Kansas, United States
Center for Pharmaceutical Research
Kansas City, Missouri, United States
Hassman Research Institute
Berlin, New Jersey, United States
Albuquerque Clinical Trials
Albuquerque, New Mexico, United States
Drug Trials America
Hartsdale, New York, United States
Rochester Clinical Research, Inc.
Rochester, New York, United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
Arcis Healthcare LLC dba Lowcountry Orthopaedics and Sports Medicine
North Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UBX0101-05
Identifier Type: -
Identifier Source: org_study_id